On October 16, 2012, Girard Gibbs filed a class action lawsuit alleging that drug manufacturer AstraZeneca entered into anticompetitive agreements designed to shield its brand-name heartburn drug, Nexium, from competition with generic, lower-priced versions of the drug. AstraZeneca entered into “pay-for-delay” agreements with generic drug manufacturers in which AstraZeneca agreed to pay substantial sums to the generic manufacturers in exchange for their agreement not to produce and market generic versions of Nexium until May 2014.
This class action is brought on behalf of all consumers and third-party payers in the United States and its territories who purchased brand-name Nexium and/or its generic equivelants since April 14, 2008. Plaintiffs seek judgment that the “pay-for-delay” agreements are unlawful under the Sherman Act and equitable relief for violations of various state antitrust, comsumer protection, and unjust erichment laws.
Girard Gibbs Named to Executive Committee in Nexium Multidistrict Litigation
Plaintiffs in states across the country filed similar cases challenging the AstraZeneca “pay-for-delay” agreements. On December 6, 2012, the Judicial Panel on Multidistrict Litigation transferred many of these cases to the District of Massachusetts for coordinated proceedings. Additional cases, including the case filed by Girard Gibbs, were also transferred to the District of Massachusetts on December 11, 2012.
Girard Gibbs managing partner, Daniel Girard, was named as a member the Executive Committee which will work with Co-Lead counsel in prosecuting the class actions brought on behalf of the indirect “end-payor” purchasers. As a member of the Executive Committee, Girard Gibbs will work on specific tasks and subcommittee responsibilities to ensure the successful and efficient prosecution of the litigation.
Nexium Personal Injury Lawsuits
In addition to litigating the Nexium antitrust class action, our attorneys are currently reviewing individual personal injury lawsuits on behalf of people who suffered kidney injuries after taking prescription or over-the-counter Nexium, Prilosec, or other proton pump inhibitor (PPI) heartburn drugs.
People who use PPIs are 20-50% more likely to develop short- and long-term kidney problems like acute interstitial nephritis (AIN), chronic kidney disease (CKD), and end-stage renal disease (ESRD), according to a study published in the Journal of the American Society of Nephrology.
If you’ve suffered kidney damage after taking Nexium, Prilosec, or other PPI heartburn medications, you may have a legal claim. Call toll-free (800) 254-5676 or fill out the form to speak privately with an attorney and get a free case review.
Our Commitment to Excellence
Girard Gibbs LLP has earned Tier-1 rankings for Mass Tort and Class Action Litigation and has been named in the U.S. News – Best Lawyers “Best Law Firms” list for four consecutive years since 2013.
We have recovered over a billion dollars for our clients against the world’s largest corporations in cases concerning auto defects, drug and medical device injuries, data breaches, securities fraud, antitrust matters, and employment law violations.
us at (800) 254-5676
us with the form to the right